Mobile oxazolidinone resistance genes in Gram-positive and Gram-negative bacteria
S Schwarz, W Zhang, XD Du, H Krüger… - Clinical microbiology …, 2021 - Am Soc Microbiol
Seven mobile oxazolidinone resistance genes, including cfr, cfr (B), cfr (C), cfr (D), cfr (E),
optrA, and poxtA, have been identified to date. The cfr genes code for 23S rRNA methylases …
optrA, and poxtA, have been identified to date. The cfr genes code for 23S rRNA methylases …
Coagulase-negative staphylococci
K Becker, C Heilmann, G Peters - Clinical microbiology reviews, 2014 - Am Soc Microbiol
The definition of the heterogeneous group of coagulase-negative staphylococci (CoNS) is
still based on diagnostic procedures that fulfill the clinical need to differentiate between …
still based on diagnostic procedures that fulfill the clinical need to differentiate between …
Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches–an overview
Antimicrobial resistance is a normal evolutionary process for microorganisms. Antibiotics
exerted accelerated selective pressure that hasten bacterial resistance through mutation …
exerted accelerated selective pressure that hasten bacterial resistance through mutation …
[HTML][HTML] Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE
infections are difficult to treat since common therapeutic options including ampicillin and …
infections are difficult to treat since common therapeutic options including ampicillin and …
Molecular mechanisms that confer antibacterial drug resistance
C Walsh - Nature, 2000 - nature.com
Antibiotics—compounds that are literally 'against life'—are typically antibacterial drugs,
interfering with some structure or process that is essential to bacterial growth or survival …
interfering with some structure or process that is essential to bacterial growth or survival …
Resistance to linezolid caused by modifications at its binding site on the ribosome
KS Long, B Vester - Antimicrobial agents and chemotherapy, 2012 - Am Soc Microbiol
Linezolid is an oxazolidinone antibiotic in clinical use for the treatment of serious infections
of resistant Gram-positive bacteria. It inhibits protein synthesis by binding to the peptidyl …
of resistant Gram-positive bacteria. It inhibits protein synthesis by binding to the peptidyl …
The bacterial ribosome as a target for antibiotics
J Poehlsgaard, S Douthwaite - Nature Reviews Microbiology, 2005 - nature.com
Many clinically useful antibiotics exert their antimicrobial effects by blocking protein
synthesis on the bacterial ribosome. The structure of the ribosome has recently been …
synthesis on the bacterial ribosome. The structure of the ribosome has recently been …
Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus
Y Gao, Y Chen, Y Cao, A Mo, Q Peng - European journal of medicinal …, 2021 - Elsevier
Abuse of antibiotics has led to the emergence of drug-resistant pathogens. Methicillin-
resistant Staphylococcus aureus (MRSA) was reported just two years after the clinical use of …
resistant Staphylococcus aureus (MRSA) was reported just two years after the clinical use of …
Linezolid: the first oxazolidinone antimicrobial
RC Moellering Jr - Annals of internal medicine, 2003 - acpjournals.org
TO THE EDITOR: In his review of linezolid, Moellering (1) appropriately calls for clinical trials
comparing the efficacy and safety of linezolid with those of other new drugs active against …
comparing the efficacy and safety of linezolid with those of other new drugs active against …
The A–Z of bacterial translation inhibitors
DN Wilson - Critical reviews in biochemistry and molecular biology, 2009 - Taylor & Francis
Protein synthesis is one of the major targets in the cell for antibiotics. This review endeavors
to provide a comprehensive “post-ribosome structure” A–Z of the huge diversity of antibiotics …
to provide a comprehensive “post-ribosome structure” A–Z of the huge diversity of antibiotics …